Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pranoprofen eye drops containing sulfobutyl ether-beta-cyclodextrin and preparation method thereof

A technology containing sulfobutyl ether and sulfobutyl ether, which is applied in the field of medicine, can solve the problems of strong irritation and low bioavailability, and achieve the effect of improving stability

Active Publication Date: 2015-10-28
SHENYANG PHARMA UNIVERSITY
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In order to overcome the shortcomings such as strong irritation and low bioavailability that common pranoprofen eye drops have, it is urgent to develop a new type of pranoprofen eye drops, which has good appearance, nontoxicity, Non-irritating, can improve patient compliance and other characteristics

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pranoprofen eye drops containing sulfobutyl ether-beta-cyclodextrin and preparation method thereof
  • Pranoprofen eye drops containing sulfobutyl ether-beta-cyclodextrin and preparation method thereof
  • Pranoprofen eye drops containing sulfobutyl ether-beta-cyclodextrin and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Embodiment 1: prepare 0.1% pranoprofen eye drops with 1% SBE-β-CD solution and 0.1% HPMC as solubilizer and stabilizer

[0022]

[0023] Preparation method: Dissolve the prescription amount of SBE-β-CD in 90mL of water for injection, add boric acid to dissolve, heat in a water bath to 60°C, add 0.1g of pranoprofen, stir until completely dissolved, add other excipients in turn, stir to make After it is completely dissolved, adjust the pH value to 7.5, and add water for injection to 100ml. Filter through a 0.22μm microporous membrane, fill in divided doses into ampoules, and obtain the product.

Embodiment 2

[0024] Embodiment 2: prepare 0.1% pranoprofen eye drops with 5% SBE-β-CD solution and 0.1% HPMC as solubilizer and stabilizer

[0025]

[0026] Preparation method: Dissolve the prescription amount of SBE-β-CD in 90mL of water for injection, add boric acid to dissolve, heat in a water bath to 60°C, add 0.1g of pranoprofen, stir until completely dissolved, add other excipients in turn, stir to make After it is completely dissolved, adjust the pH value to 7.5, and add water for injection to 100ml. Filter through a 0.22μm microporous membrane, fill in divided doses into ampoules, and obtain the product.

Embodiment 3

[0027] Embodiment 3: prepare 0.1% pranoprofen eye drops with 10% SBE-β-CD solution and 0.1% HPMC as solubilizer and stabilizer

[0028]

[0029] Preparation method: Dissolve the prescription amount of SBE-β-CD in 90mL of water for injection, add boric acid to dissolve, heat in a water bath to 60°C, add 0.1g of pranoprofen, stir until completely dissolved, add other excipients in turn, stir to make After it is completely dissolved, adjust the pH value to 7.5, and add water for injection to 100ml. Filter through a 0.22μm microporous membrane, fill in divided doses into ampoules, and obtain the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and discloses pranoprofen eye drops containing sulfobutyl ether-beta-cyclodextrin. The pranoprofen eye drops comprise active component pranoprofen, the solubilizer sulfobutyl ether-beta-cyclodextrin, a stabilizer, a pH conditioning agent, a bacteriostatic agent and an osmotic pressure conditioning agent. The stabilizer is one or the mixture of a high-molecular polymer polyethylene glycol, polyving akohol, povidone, polyvinylpyrrolidone, sodium hyaluronate, poloxamer and hydroxypropyl methylcellulose. According to the preparation method, SBE-beta-CD is dissolved into water for injection to be heated at the temperature of 60 DEG C, the pranoprofen is added so as to be dissolved completely, the other auxiliary materials are added in sequence, stirring is performed until thorough dissolving, then, the mixture is cooled to the room temperature, the pH value is conditioned, water for injection is replenished, and the mixture is filtered through a 0.22-micrometer micropore filter membrane to obtain the pranoprofen eye drops. According to the pranoprofen eye drops containing the sulfobutyl ether-beta-cyclodextrin, using irritation to the eyes is lowered, and the stability is remarkably improved.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to a pranoprofen eye drop and a preparation technology thereof, in particular to a pranoprofen eye drop containing sulfobutyl ether-β-cyclodextrin and a preparation method thereof. Background technique [0002] At present, the commonly used drugs for clinical treatment of various eye inflammation and allergic symptoms are antihistamines, anticongestants, corticosteroids, mast cell stabilizers and non-steroidal anti-inflammatory agents. Long-term use of antihistamines, anticongestants, corticosteroids, and mast cell stabilizers may lead to a decline in adrenal cortex function and induce serious adverse reactions. Non-steroidal anti-inflammatory drugs have no adverse reactions of corticosteroids, and have anti-inflammatory, analgesic and anti-allergic effects, so they are widely used in ophthalmology. [0003] Pranoprofen eye drops are the eye drops of propionate non-steroidal anti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/08A61K31/436A61K47/40A61P27/02
Inventor 王永军薛鹏王晶何仲贵
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products